PLEASANTON, Calif., Oct. 1, 2024 /PRNewswire/ -- At the Human Cell Atlas General Meeting held September 29-30 in Milan, Italy, 10x Genomics, Inc. (TXG) (Nasdaq: TXG), a leader in single cell and ...

PLEASANTON, Calif., Oct. 15, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium products intended to ...

The MarketWatch News Department was not involved in the creation of this content. "Transforming Biological Research and Personalized Medicine: Single-Cell Genomics and Proteomics Show Cellular ...

Genomics, Inc. (NASDAQ:TXG) is one of the best digital health stocks to buy now. On October 29, 2025, 10x Genomics announced the launch of its next-generation Chromium Flex assay, designed to help ...

10x Genomics, a company focused on accelerating discovery, today announced the launch of the Single Cell Mouse Immune Profiling Solution. For the first time, researchers will have the ability to ...

Bundled offerings will further strengthen Fluent's competitive edge with low-cost positioning. Fluent's PIPseq single-cell technology does not require an instrument, and costs per cell is at least 50% ...

LIVERMORE, Calif.--(BUSINESS WIRE)--S2 Genomics, a manufacturer of automated tissue sample preparation systems, announced today at the Advances in Genome Biology and Technology (AGBT) 2020 meeting the ...

"Transforming Biological Research and Personalized Medicine: Single-Cell Genomics and Proteomics Show Cellular Heterogeneity, Driving Advances in Disease Mechanisms, Drug Discovery, and Precision ...